Hans-Peter Stoll

Showing 1-8 of 8 articles

Author Kuniaki Takahashi

Coronary interventions

Impact of Ticagrelor Monotherapy on Two-Year Clinical Outcomes in Patients with Long Stenting: A Post Hoc Analysis of the Global Leaders Trial

Takahashi K, Chichareon P, Modolo R, Kogame N, Chang C, Tomaniak M, Moschovitis A, Curzen N, Haude M, Jung W, Holmvang L, Garg S, Tijssen J, Wykrzykowska J, de Winter R, Hamm C, Steg P, Stoll H-P, Onuma Y, Valgimigli M, Vranckx P, Windecker S, Serruys P

September 10, 2019 | 10.4244/EIJ-D-19-00498

Author Wai Luen Stephen Lee

Coronary interventions

Establishment of healing profile and neointimal transformation in the new polymer-free biolimus A9-coated coronary stent by longitudinal sequential optical coherence tomography assessments: the EGO-BIOFREEDOM study

Lee WLS, Tam FCC, Chan KKW, Lam S, Kong S-L, Shea CP, Wong MKL, Wong AYT, Yung ASY, Zhang L-W, Lam Y-M, Mintz G, Costa R, Stoll H-P, Maehara A

September 20, 2018 | 10.4244/EIJ-D-18-00061

Author Janusz Lipiecki

Biolimus A9 polymer-free coated stents in high bleeding risk patients undergoing complex PCI: evidence from the LEADERS FREE randomised clinical trial

Lipiecki J, Brunel P, Morice M, Roguelov C, Walsh S, Richardt G, Eerdmans P, Zambahari R, Berland J, Copt S, Stoll H-P, Urban P

July 20, 2018 | 10.4244/EIJ-D-18-00293

Author Christoph J. Jensen

Two-year outcomes of high bleeding risk patients with acute coronary syndrome after Biolimus A9 polymer-free drug-coated stents: a LEADERS FREE substudy

Jensen C, Naber C, Urban P, Ong PJ, Valdés Chávarri M, Abizaid A, Pocock S, Fabbiocchi F, Dubois C, Copt S, Stoll H-P, Morice M

March 20, 2018 | 10.4244/EIJ-D-17-00720

Author Florim Cuculi

Outcomes in patients undergoing multivessel percutaneous coronary intervention using sirolimus-eluting stents: a report from the e-SELECT registry

Cuculi F, Banning A, Abizaid A, Bartorelli A, Baux A, Dzavik V, Ellis SG, Gao R, Holmes D, Jeong M, Legrand V, Neumann F-J, Nyakern M, Spaulding C, Stoll H-P, Worthley S, Urban P

December 30, 2011 | 10.4244/EIJV7I8A152

Author S Vaina

Effect of gender differences on early and mid-term clinical outcome after percutaneous or surgical coronary revascularisation in patients with multivessel coronary artery disease: Insights from ARTS I and ARTS II

Vaina S, Voudris V, Morice M, de Bruyne B, Colombo A, Macaya C, Richardt G, Fajadet J, Hamm C, Schuijer M, Macours N, Stoll H-P, Cokkinos D, Stefanadis C, Serruys P

January 20, 2009

Author Patrick Serruys

Three-year follow-up of the ARTS-II# – Sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease

Serruys P, Daemen J, Morice M, de Bruyne B, Colombo A, Macaya C, Richardt G, Fajadet J, Hamm C, Dawkins K, Vranckx P, Bressers M, van Domburg R, Schuijer M, Wittebols K, Pieters M, Stoll H-P

January 20, 2008

Author Carlos Macaya

One-year results of coronary revascularization in diabetic patients with multivessel coronary artery disease.

Macaya C, Garcia-Garcia H, Colombo A, Morice M, Legrand V, Kuck K-H, Sheiban I, Suttorp MJ, Carrié D, Vrolix M, Wittebols K, Stoll H-P, Donohoe D, Bressers M, Serruys P

May 20, 2006

1

Latest news

TAVR in sarcopaenia; CCTA or TEE in LAAC; Iintravascular lithotripsy, read the new issue

(CT scans of a sarcopaenic patient)

October 18, 2019

The SYNTAX score on its way out or … towards artificial intelligence

November 1, 2019

New this week: Deep Learning, near-infrared spectroscopy and much more

November 12, 2019

New update! Discover 17 new trials

(The Trials book is supported by Biotronik)

October 29, 2019

Guidelines, consensus & position papers

Medical device regulation in Europe – what is changing and how can I become more involved?

October 18, 2019

Last week's JAA's: 1-year EffPac trial results & Sheathless vs conventional access

November 5, 2019

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke